Tokyo, April 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061221) titled 'Upfront tandem versus superior-first approach for transvenous lead extraction: a Japanese single-center experience' on April 10.
Study Type:
Observational
Primary Sponsor:
Institute - Sendai Kousei Hospital
Condition:
Condition - Consecutive patients who underwent TLE between September 2014 and March 2026.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - By focusing on the timing of femoral access, this study aimed to determine whether an upfront tandem approach can achieve comparable procedural success with similar safety and to inform extraction strategies for complex cases.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Consecutive patients who underwent TLE between September 2014 and March 2026.
Key exclusion criteria - The patients were excluded if they underwent planned hybrid TLE requiring thoracotomy.
Target Size - 300
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2014 Year 09 Month 01 Day
Date of IRB - 2025 Year 10 Month 23 Day
Anticipated trial start date - 2014 Year 09 Month 01 Day
Last follow-up date - 2026 Year 04 Month 08 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069993
Disclaimer: Curated by HT Syndication.
